Pfizer Misses Q4 Earnings Estimates – Is the Stock’s 5-Month Rally Alive and Well?
Pharmaceutical giant Pfizer (NYSE: PFE) announced fourth quarter results that missed expectations.
Revenue came in at $12.69 billion, a bit shy of the consen... Read More»